Multicentre 12‐week double‐blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.

British Journal of Clinical Pharmacology

Volumn 21, Issue 1 S, 1986, Pages 69S-75S

  Torvik, D ^a   Madsbu, HP ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOXAZOSIN; PLACEBO; PRAZOSIN;

ADVERSE DRUG REACTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOVASCULAR SYSTEM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG THERAPY; FATIGUE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPERTENSION; INTOXICATION; LIPID BLOOD LEVEL; LIVER TOXICITY; MAJOR CLINICAL STUDY; NAUSEA; NERVOUS SYSTEM; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THERAPY; TRIACYLGLYCEROL BLOOD LEVEL; VERTIGO;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BODY WEIGHT; CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DOXAZOSIN; FEMALE; HUMAN; HYPERTENSION; LIPIDS; MALE; MIDDLE AGE; PRAZOSIN; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T;

EID: 0023034681     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1986.tb02856.x     Document Type: Article

References (29)

1. Single daily dose of antidepressants
2. Effect of placebo therapy on blood pressure
3. Epidemiology of coronary heart disease: the Framingham Study
4. A pharmacokinetic and pharmacodynamic assessment of a new alpha‐adrenoceptor antagonist, doxazosin (UK‐33, 274) in normotensive subjects
5. To be taken as directed
6. Effects of alpha‐ and beta‐blocker antihypertensive therapy on blood lipids. A multicentre trial
7. Can placebo therapy influence arterial blood pressure
8. Treatment of mild hypertension. A five year controlled drug trial
9. High‐density lipoprotein cholesterol and antihypertensive drugs: The Oslo Study
10. Five years findings of the hypertension detection and follow‐up program: reduction in mortality in persons with high pressure, including mild hypertension
11. Effect of prazosin on serum lipids
12. Effects of antihypertensive therapy on serum lipids and lipoproteins in the Multiple Risk Factor Intervention Trial
13. High density lipoproteins and the risk of atherosclerosis
14. Double‐blind comparison of the effects of long‐term treatment with doxazosin or atenolol on serum lipoproteins
15. Effects of alpha and beta‐blocker antihypertensive therapy on blood lipids: European experience
16. Effects of propranolol and prazosin on blood lipids. The Oslo Study
17. The antihypertensive effect of prazosin on mild to moderate hypertension, changes in plasma volume, extracellular volume and glomerular filtration rate
18. The Australian therapeutic trial in mild hypertension
19. Kostholdsbehandling av essensiell hypertensjon
20. The Tromsø Heart Study. High density lipoprotein and coronary heart disease: a prospective case control study
21. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure
22. Treatment of mild hypertension; results of a 10 year intervention trial
23. Effect of prazosin on blood lipids and thyroid function in hypertensive patients
24. Effects of treatment on morbidity in hypertension; results in patients with diastolic blood pressure averaging 115–129 mmHg
25. Effects of treatment on morbidity in hypertension; results in patients with diastolic blood pressure averaging 90–114 mmHg
26. 1‐adrenoceptor antagonist: pharmacokinetics and concentration effect relationships in man
27. Influence of weight reduction on plasma lipoproteins in obese patients